Gelonghui, April 23 | Aiwei Technology (688067.SH) said on the investor interactive platform that the company's Helicobacter pylori test reagent did not involve C-14, and its localization had no impact on the company.
爱威科技(688067.SH)：公司幽门螺旋杆菌检测试剂未涉及到C-14
Aiwei Technology (688067.SH): The company's Helicobacter pylori test reagents did not involve C-14
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.